Treatment

Total of patients n (%)

Type of hormonal therapy neo-adjuvant (n = 57)

Letrozole

Anastrazole

Exemestane

45 (78.9)

11 (19.3)

1 (1.8)

Indication for hormonal therapy (n = 57)

Locally advanced tumor

Poor breast-tumor relationship

Comorbidities

Others

27 (47.4)

14 (24.6)

6 (10.5)

10 (17.5)

Neo-adjuvant hormonal therapy duration (n = 57)

Less than 4 months

4 to 6 months

More than 6 months

11 (19.3)

18 (31.6)

28 (49.1)

Surgical treatment (n = 51)

Lumpectomy + sentinel lymph node biopsy

Lumpectomy + axillary lymph node dissection

Simple mastectomy + sentinel lymph node biopsy

Simple mastectomy + axillary lymph node dissection

14 (27.5)

15 (29.4)

4 (7.8)

18 (35.3)

Adjuvant treatment (n = 51)

Hormonal therapy

Chemotherapy

Radiotherapy

50 (98.0)

12 (23.5)

37 (72.5)